The New Oral Anticoagulants in Clinical Practice
The New Oral Anticoagulants in Clinical Practice
About this item
Full title
Author / Creator
Publisher
England: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Abstract Vitamin K antagonists were the only class of oral anticoagulants available to clinicians for decades. However, with the US Food and Drug Administration approval of new oral anticoagulants, such as dabigatran, rivaroxaban, and apixaban, clinicians now have a broader choice. Given the recent approval and availability of these medications, se...
Alternative Titles
Full title
The New Oral Anticoagulants in Clinical Practice
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1348504259
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1348504259
Other Identifiers
ISSN
0025-6196
E-ISSN
1942-5546
DOI
10.1016/j.mayocp.2013.03.006
